Licensed protein subunit RSV vaccine (primary dose)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Licensed protein subunit RSV vaccine (primary dose), covering 2026-01-30 to 2026-01-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study of mRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) Vaccine in Adult Participants ≥60 Years of Age [Phase 3]